| 臺大學術典藏 |
2022-09-15T05:42:25Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2022-09-09T04:21:41Z |
Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease
|
Huang S.-C.; Su H.-J.; JIA-HORNG KAO; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; Liu C.-J. |
| 臺大學術典藏 |
2022-09-09T04:21:40Z |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin S.-R.; Yang T.-Y.; Peng C.-Y.; Lin Y.-Y.; Dai C.-Y.; Wang H.-Y.; Su T.-H.; Tseng T.-C.; Liu I.-J.; Cheng H.-R.; Shen Y.-C.; Wu F.-Y.; Liu C.-J.; Chen D.-S.; Chen P.-J.; Yang H.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:39Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:38Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:37Z |
Three heads are better than two: Hepatitis b core-related antigen as a new predictor of hepatitis b virus-related hepatocellular carcinoma
|
Wu J.-W.; JIA-HORNG KAO; Tseng T.-C. |
| 臺大學術典藏 |
2022-09-09T04:21:32Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:29Z |
Looking Into the Crystal Ball: A Novel Biomarker for Outcomes of Patients With Chronic Hepatitis B Virus Infection
|
Tseng T.-C.; Wu J.-W.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:29Z |
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
|
Lin C.-L.; Tai C.-M.; Huang J.-F.; Liu C.-J.; Chen H.-F.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Wang C.-C.; Weng S.-H.; Tseng T.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO |
